Nicotinamide N-Methyltransferase
"Nicotinamide N-Methyltransferase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An enzyme found primarily in the LIVER that catalyzes the N-methylation of NICOTINAMIDE and other structurally related compounds.
| Descriptor ID |
D050903
|
| MeSH Number(s) |
D08.811.913.555.500.650
|
| Concept/Terms |
Nicotinamide N-Methyltransferase- Nicotinamide N-Methyltransferase
- N-Methyltransferase, Nicotinamide
- Nicotinamide N Methyltransferase
- Nicotinamide-S-Adenosylmethionine Methyltransferase
- Methyltransferase, Nicotinamide-S-Adenosylmethionine
- Nicotinamide S Adenosylmethionine Methyltransferase
- Nicotinamide Methylase
- Methylase, Nicotinamide
- Nicotinamide Methyltransferase
- Methyltransferase, Nicotinamide
|
Below are MeSH descriptors whose meaning is more general than "Nicotinamide N-Methyltransferase".
Below are MeSH descriptors whose meaning is more specific than "Nicotinamide N-Methyltransferase".
This graph shows the total number of publications written about "Nicotinamide N-Methyltransferase" by people in this website by year, and whether "Nicotinamide N-Methyltransferase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2019 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nicotinamide N-Methyltransferase" by people in Profiles.
-
NNMT contributes to high metastasis of triple negative breast cancer by enhancing PP2A/MEK/ERK/c-Jun/ABCA1 pathway mediated membrane fluidity. Cancer Lett. 2022 10 28; 547:215884.
-
Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization. Breast Cancer Res. 2019 05 17; 21(1):64.